WG Biotech ApS: Financial statements 2017
CVR: 36940131
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
WG Biotech ApS (CVR 36940131) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK -220,191 compared with DKK -265,432 the year before. Equity in the 2017 report amounted to DKK -424,581.
- Profit/Loss
- DKK -220,191
- Equity
- DKK -424,581
- Total Assets
- DKK 6,708,361
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | - | -220 t. | -425 t. | - |
| 2016 | - | - | -265 t. | -204 t. | - |
Official annual report
Keep an eye on WG Biotech ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
WG Biotech ApS has published its annual report for 2016. The net result was DKK -265,432.
About WG Biotech ApS
WG Biotech ApS is a Danish company of the type Anpartsselskab based in Rungsted Kyst, founded in 2015. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Johan Ernst Wedell-Wedellsborg. The company is owned by WECO A/S and WG Biotech ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,963,000 and a net result of DKK 2,166,000 compared with DKK 48,534,000 the year before. Equity in the 2025 report amounted to DKK 311,608,000.